NEUROD1 and small cell lung carcinoma: Gay et al. have identified four SCLC subtypes based on the expression of three transcription factors (i.e., ASCL1, NEUROD1, and POU2F3); if those are all not expressed, an inflamed gene signature showed a similar correlation between SCLC subtypes and their vulnerability to specific drugs (52).